← Open Payments lookup

LI LIANG: Open Payments

NPI 1053468546 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,199 in 46 payments from 12 companies in 2025. Trend: 2023 $1,475 · 2024 $1,251 · 2025 $1,199

Food & beverage: $1,199
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$282
Otsuka America Pharmaceutical, Inc.6$221
Alkermes, Inc.8$151
Lundbeck LLC7$145
Corcept Therapeutics1$104
ABBVIE INC.4$86
Axsome Therapeutics, Inc.3$83
Vanda Pharmaceuticals Inc.2$56
E.R. Squibb & Sons, L.L.C.1$24
TMS NeuroHealth Centers Inc.1$18

Products named: REXULTI, CAPLYTA, ARISTADA, Korlym, VRAYLAR, Auvelity, FANAPT, COBENFY.

Industry payments across CA — which companies pay providers there.